A citation-based method for searching scientific literature

Katsuomi Iwakura, Hiroshi Ito, Masashi Ikushima, Shigeo Kawano, Atsushi Okamura, Katsuaki Asano, Tadashi Kuroda, Koji Tanaka, Tohru Masuyama, Masatsugu Hori, Kenshi Fujii. J Am Coll Cardiol 2003
Times Cited: 289







List of co-cited articles
665 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Myocardial no-reflow in humans.
Giampaolo Niccoli, Francesco Burzotta, Leonarda Galiuto, Filippo Crea. J Am Coll Cardiol 2009
538
20

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.
Gjin Ndrepepa, Klaus Tiroch, Massimiliano Fusaro, Dritan Keta, Melchior Seyfarth, Robert A Byrne, Jürgen Pache, Patricia Alger, Julinda Mehilli, Albert Schömig,[...]. J Am Coll Cardiol 2010
288
15

Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
Robert W Harrison, Atul Aggarwal, Fang-shu Ou, Lloyd W Klein, John S Rumsfeld, Matthew T Roe, Tracy Y Wang. Am J Cardiol 2013
133
15

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.
R A Kloner, C E Ganote, R B Jennings. J Clin Invest 1974
14

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod, Saif S Rathore, Silvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, Edward P Havranek, Harlan M Krumholz. Circulation 2005
433
13

Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?
Nazneem N Wahab, Elizabeth A Cowden, Neil J Pearce, Martin J Gardner, Heather Merry, Jafna L Cox. J Am Coll Cardiol 2002
290
13

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
Borja Ibanez, Stefan James, Stefan Agewall, Manuel J Antunes, Chiara Bucciarelli-Ducci, Héctor Bueno, Alida L P Caforio, Filippo Crea, John A Goudevenos, Sigrun Halvorsen,[...]. Eur Heart J 2018
13

Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
Hon-Kan Yip, Mien-Cheng Chen, Hsueh-Wen Chang, Chi-Ling Hang, Yuan-Kai Hsieh, Chih-Yuan Fang, Chiung-Jen Wu. Chest 2002
226
12


Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
Ischa Stranders, Michaela Diamant, Rogier E van Gelder, Hugo J Spruijt, Jos W R Twisk, Robert J Heine, Frans C Visser. Arch Intern Med 2004
252
12

Thrombus aspiration during primary percutaneous coronary intervention.
Tone Svilaas, Pieter J Vlaar, Iwan C van der Horst, Gilles F H Diercks, Bart J G L de Smet, Ad F M van den Heuvel, Rutger L Anthonio, Gillian A Jessurun, Eng-Shiong Tan, Albert J H Suurmeijer,[...]. N Engl J Med 2008
772
12

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.
K C Wu, E A Zerhouni, R M Judd, C H Lugo-Olivieri, L A Barouch, S P Schulman, R S Blumenthal, J A Lima. Circulation 1998
12

Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center.
Cevat Kirma, Akin Izgi, Cihan Dundar, Ali Cevat Tanalp, Vecih Oduncu, Soe Moe Aung, Kenan Sonmez, Bulent Mutlu, Nihal Ozdemir, Vedat Erentug. Circ J 2008
67
16

Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.
C M Gibson, J A de Lemos, S A Murphy, S J Marble, C H McCabe, C P Cannon, E M Antman, E Braunwald. Circulation 2001
353
11

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.
Ronen Jaffe, Thierry Charron, Geoffrey Puley, Alexander Dick, Bradley H Strauss. Circulation 2008
240
11



Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.
K Iwakura, H Ito, S Kawano, Y Shintani, K Yamamoto, A Kato, M Ikushima, K Tanaka, M Kitakaze, M Hori,[...]. J Am Coll Cardiol 2001
138
10

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
Jorik R Timmer, Miriam Hoekstra, Maarten W N Nijsten, Iwan C C van der Horst, Jan Paul Ottervanger, Robbert J Slingerland, Jan-Henk E Dambrink, Henk J G Bilo, Felix Zijlstra, Arnoud W J van 't Hof. Circulation 2011
156
10

Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.
Masaharu Ishihara, Sunao Kojima, Tomohiro Sakamoto, Yujiro Asada, Chuwa Tei, Kazuo Kimura, Shunichi Miyazaki, Masahiro Sonoda, Kazufumi Tsuchihashi, Masakazu Yamagishi,[...]. Am Heart J 2005
130
10


Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Gjin Ndrepepa, Klaus Tiroch, Dritan Keta, Massimiliano Fusaro, Melchior Seyfarth, Jürgen Pache, Julinda Mehilli, Albert Schömig, Adnan Kastrati. Circ Cardiovasc Interv 2010
111
10

Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention.
Hua Zhou, Xiao-Yan He, Shao-Wei Zhuang, Juan Wang, Yan Lai, Wei-Gang Qi, Yi-An Yao, Xue-Bo Liu. World J Emerg Med 2014
36
27


Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, Jan-Henk E Dambrink, Jan C A Hoorntje, A T Marcel Gosselink, Harry Suryapranata, Felix Zijlstra, Arnoud W J van 't Hof. J Am Coll Cardiol 2005
105
9

Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction.
Masaharu Ishihara, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Kenji Nishioka, Takashi Umemura, Shuji Nakamura, Masashi Yoshida. Am Heart J 2003
99
9


Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
Marcelo F Di Carli, James Janisse, George Grunberger, Joel Ager. J Am Coll Cardiol 2003
283
9

Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction.
Leonardo Bolognese, Nazario Carrabba, Guido Parodi, Giovanni M Santoro, Piergiovanni Buonamici, Giampaolo Cerisano, David Antoniucci. Circulation 2004
302
9

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
C M Gibson, C P Cannon, S A Murphy, K A Ryan, R Mesley, S J Marble, C H McCabe, F Van De Werf, E Braunwald. Circulation 2000
661
8


No-reflow phenomenon.
Shereif H Rezkalla, Robert A Kloner. Circulation 2002
414
8

The "no-reflow" phenomenon: basic science and clinical correlates.
Thorsten Reffelmann, Robert A Kloner. Heart 2002
233
8

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.
Anna Norhammar, Ake Tenerz, Göran Nilsson, Anders Hamsten, Suad Efendíc, Lars Rydén, Klas Malmberg. Lancet 2002
760
8

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Ph Gabriel Steg, Stefan K James, Dan Atar, Luigi P Badano, Carina Blömstrom-Lundqvist, Michael A Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles,[...]. Eur Heart J 2012
8

Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome.
Raffaele Marfella, Mario Siniscalchi, Katherine Esposito, Ausilia Sellitto, Umberto De Fanis, Ciro Romano, Michele Portoghese, Silvio Siciliano, Francesco Nappo, Ferdinando Carlo Sasso,[...]. Diabetes Care 2003
132
8

TIMI frame count: a quantitative method of assessing coronary artery flow.
C M Gibson, C P Cannon, W L Daley, J T Dodge, B Alexander, S J Marble, C H McCabe, L Raymond, T Fortin, W K Poole,[...]. Circulation 1996
8

Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.
David Brosh, Abid R Assali, Aviv Mager, Avital Porter, David Hasdai, Igal Teplitsky, Eldad Rechavia, Shmuel Fuchs, Alexander Battler, Ran Kornowski. Am J Cardiol 2007
155
8

Novel insights into an "old" phenomenon: the no reflow.
Alessandro Durante, Paolo G Camici. Int J Cardiol 2015
64
12

A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
David Carrick, Keith G Oldroyd, Margaret McEntegart, Caroline Haig, Mark C Petrie, Hany Eteiba, Stuart Hood, Colum Owens, Stuart Watkins, Jamie Layland,[...]. J Am Coll Cardiol 2014
154
8

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Prakash Deedwania, Mikhail Kosiborod, Eugene Barrett, Antonio Ceriello, William Isley, Theodore Mazzone, Philip Raskin. Circulation 2008
311
8

Randomized trial of primary PCI with or without routine manual thrombectomy.
Sanjit S Jolly, John A Cairns, Salim Yusuf, Brandi Meeks, Janice Pogue, Michael J Rokoss, Sasko Kedev, Lehana Thabane, Goran Stankovic, Raul Moreno,[...]. N Engl J Med 2015
367
8

Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention.
Yundai Chen, Changhua Wang, Xinchun Yang, Lefeng Wang, Zhijun Sun, Hongbin Liu, Lian Chen. Heart Vessels 2012
24
29

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
Mikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, Lan Xiao, Philip G Jones, Suzanne Fiske, Frederick A Masoudi, Steven P Marso, John A Spertus. Circulation 2008
284
7

Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients.
Matthijs van Kranenburg, Michael Magro, Holger Thiele, Suzanne de Waha, Ingo Eitel, Alexandre Cochet, Yves Cottin, Dan Atar, Peter Buser, Edwin Wu,[...]. JACC Cardiovasc Imaging 2014
187
7

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, S Efendic, M Fisher, A Hamsten, J Herlitz,[...]. Eur Heart J 2005
709
7

Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial.
Francesco Burzotta, Carlo Trani, Enrico Romagnoli, Mario Attilio Mazzari, Antonio Giuseppe Rebuzzi, Maria De Vita, Barbara Garramone, Floriana Giannico, Giampaolo Niccoli, Giuseppe G L Biondi-Zoccai,[...]. J Am Coll Cardiol 2005
281
7

Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.
G A Oswald, C C Smith, D J Betteridge, J S Yudkin. Br Med J (Clin Res Ed) 1986
231
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.